| Cassandra Joe Curry, | |
|
7830 Highway 72 W, Madison, AL 35758-9500 | |
| (256) 864-0511 | |
| Not Available |
| Full Name | Cassandra Joe Curry |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 7830 Highway 72 W, Madison, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114403441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 20496 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cassandra Joe Curry, 500 Providence Main St Nw Apt 10302, Huntsville, AL 35806-4895 Ph: (256) 468-2049 | Cassandra Joe Curry, 7830 Highway 72 W, Madison, AL 35758-9500 Ph: (256) 864-0511 |
News Archive
Surgical Risk Solutions, LLC announced today the introduction of a unique new insurance product designed to provide financial resources to surgical patients in the event that they have adverse outcomes following surgery.
The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
Celldex Therapeutics, Inc. today announced that the Company presented initial clinical data on CDX-1401 at the 25th Annual Meeting of the International Society of Biological Therapy of Cancer (iSBTc) in Washington, DC. CDX-1401 is a novel antibody-based targeted cancer vaccine candidate being evaluated as a treatment for patients with melanoma and other cancers that are known to express the tumor antigen NY-ESO-1.
In tandem with the Food and Drug Administration's quest to dramatically reduce Salmonella-related food poisoning, National Pasteurized Eggs (NPE) www.SafeEggs.com, the country's largest shell egg pasteurizer, opened a new state-of-the-art plant that more than doubles its production and expands Americans' access to eggs free from dangerous egg-related Salmonella-enteritidis.
› Verified 1 days ago
Ayah Abu-spetani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12010 County Line Rd, Madison, AL 35756 Phone: 256-230-6345 | |
Dr. Paige Pettaway, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 298 Hughes Rd, Madison, AL 35758 Phone: 256-464-3962 Fax: 256-464-9654 | |
Dr. Nanci Castillo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12010 County Line Rd, Madison, AL 35756 Phone: 910-230-6345 | |
Abreah E Cannon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8000 Madison Blvd, Madison, AL 35758 Phone: 256-461-6903 | |
Jennifer Reeves Burcham, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8000 Madison Blvd Ste B, Madison, AL 35758 Phone: 256-461-6903 | |
Dr. Naya Topadze Mason, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7813 Highway 72 W, Madison, AL 35758 Phone: 256-895-9326 Fax: 256-895-9879 |